Inotiv Buys Pathology Services Provider Histion
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) has acquired Histion LLC, a provider of preclinical laboratory services. While financial terms of the acquisition were not disclosed, Inotiv says it adds a strategic element to the expansion of its specialized pathology services.
“The acquisition of Histion extends our histology operations into highly-specialized plastics and medical device pathology,” said Greg Beattie, chief operating officer of discovery and development services at Inotiv. “This acquisition will also support the previously announced expansion of our surgical model and medical device testing services in Fort Collins, CO, and will accelerate the development of these services and our future expansion plans.”
Earlier this year, Inotiv acquired Orient BioResource Center Inc. in Texas.
“We have a valued, longstanding history of working with Histion, and are confident that the addition of Histion’s expert team will enable us to better assist our clients in study design and the effective evaluation of the safety and efficacy of medical devices across a very broad array of therapeutic indications,” said Beattie.
Inotiv is a medical technology company that specializes in nonclinical and analytical contract pharmaceutical services.